Association of mindfulness-based stress reduction added to dexmedetomidine with patient-reported outcomes in permanent enterostomy: A retrospective cohort study

BACKGROUND Permanent enterostomy, including colostomy and ileostomy, is common in colorectal cancer and causes body image changes, abnormal defecation, and stigma.Patients often develop clinically significant anxiety and/or depressive symptoms.Dexmedetomidine provides short-term relief but does not address long-term psychosocial adaptation.Mindfulness-based stress reduction (MBSR) may complement dexmedetomidine, but evidence in this population is limited.AIM To investigate the association between MBSR added to dexmedetomidine and outcomes in permanent enterostomy with anxiety and/or depressive symptoms.METHODS This single-center, nonrandomized, retrospective comparative cohort study included 120 patients with permanent enterostomy (including colostomy and ileostomy) and clinically significant anxiety and/or depressive symptoms [Hospital Anxiety and Depression Scale (HADS)-A ≥ 8 and/or HADS-D ≥ 8] from January 2016 to December 2025.Patients selfselected MBSR: Observation group (n = 63) received dexmedetomidine plus MBSR; control group (n = 57) received dexmedetomidine plus routine care.Outcomes were assessed using the HADS, Stoma Quality of Life Scale, General Self-Efficacy Scale, and Ostomy Adjustment Inventory-20. RESULTSRepeated-measures showed significant group main effect and time × group interaction for HADS (both P < 0.05).At discharge and post-treatment, HADS-A and HADS-D scores were lower in the observation group than in the control group (both P < 0.01).Post-4 / 37 treatment Stoma Quality of Life Scale total score was higher in the observation group (62.63 ± 5.60 vs 54.30 ± 6.78, P < 0.001).General Self-Efficacy Scale score was higher in the observation group (29.14 ± 4.65 vs 26.68 ± 4.64, P = 0.005).Ostomy Adaptation Scale score was higher in the observation group (69.16 ± 7.65 vs 63.42 ± 7.85, P < 0.001). CONCLUSIONAdding MBSR to dexmedetomidine was positively associated with improved anxiety, depression, quality of life, self-efficacy, and psychosocial adaptation in permanent enterostomy patients.These exploratory findings require randomized confirmation.

Authors

Institutions

Publication Details

Journal
World Journal of Psychiatry
Published
2026-11-16
DOI
https://doi.org/10.5498/wjp.124966
Primary Topic
Stoma care and complications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of mindfulness-based stress reduction added to dexmedetomidine with patient-reported outcomes in permanent enterostomy: A retrospective cohort study

Nan Chen, Yan Chen, Zhao-Wei Zhu, Zhen-Zhen Zhou et al.
1 links
World Journal of Psychiatry
Stoma care and complications
article

Association of mindfulness-based stress reduction added to dexmedetomidine with patient-reported outcomes in permanent enterostomy: A retrospective cohort study

Nan Chen, Yan Chen, Zhao-Wei Zhu, Zhen-Zhen Zhou, Nan Yao
article en

Abstract

BACKGROUND Permanent enterostomy, including colostomy and ileostomy, is common in colorectal cancer and causes body image changes, abnormal defecation, and stigma.Patients often develop clinically significant anxiety and/or depressive symptoms.Dexmedetomidine provides short-term relief but does not address long-term psychosocial adaptation.Mindfulness-based stress reduction (MBSR) may complement dexmedetomidine, but evidence in this population is limited.AIM To investigate the association between MBSR added to dexmedetomidine and outcomes in permanent enterostomy with anxiety and/or depressive symptoms.METHODS This single-center, nonrandomized, retrospective comparative cohort study included 120 patients with permanent enterostomy (including colostomy and ileostomy) and clinically significant anxiety and/or depressive symptoms [Hospital Anxiety and Depression Scale (HADS)-A ≥ 8 and/or HADS-D ≥ 8] from January 2016 to December 2025.Patients selfselected MBSR: Observation group (n = 63) received dexmedetomidine plus MBSR; control group (n = 57) received dexmedetomidine plus routine care.Outcomes were assessed using the HADS, Stoma Quality of Life Scale, General Self-Efficacy Scale, and Ostomy Adjustment Inventory-20. RESULTSRepeated-measures showed significant group main effect and time × group interaction for HADS (both P < 0.05).At discharge and post-treatment, HADS-A and HADS-D scores were lower in the observation group than in the control group (both P < 0.01).Post-4 / 37 treatment Stoma Quality of Life Scale total score was higher in the observation group (62.63 ± 5.60 vs 54.30 ± 6.78, P < 0.001).General Self-Efficacy Scale score was higher in the observation group (29.14 ± 4.65 vs 26.68 ± 4.64, P = 0.005).Ostomy Adaptation Scale score was higher in the observation group (69.16 ± 7.65 vs 63.42 ± 7.85, P < 0.001). CONCLUSIONAdding MBSR to dexmedetomidine was positively associated with improved anxiety, depression, quality of life, self-efficacy, and psychosocial adaptation in permanent enterostomy patients.These exploratory findings require randomized confirmation.

World Journal of Psychiatry
Hebei Mental Health Center (CN)
Good health and well-being
Stoma care and complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon